IL17A and pulmonary fibrosis: They can inhibit lung inflammation and pulmonary fibrosis, resulting in their apparent inhibition of inflammatory factors such as TNF-α, IL-6, IL-1β, and IL-17 (Du et al., 2020; Liu et al., 2022).